logo

FDA Calendar

Share
Company Name MorphoSys AG
Drug Name Tafasitamab (BLA)
Event Name FDA decision on Tafasitamab for the treatment of relapsed or refractory diffuse large B cell lymphoma.
Event Date 08/30/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar

>